Lista de obras -

5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials ⬇️

artículo científico publicado el 24 de abril de 2011

A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer ⬇️

artículo científico publicado el 11 de febrero de 2011

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials ⬇️

artículo científico publicado el 5 de octubre de 2011

Benefit of adjuvant chemotherapy in elderly ER-negative breast cancer patients: benefits and pitfalls

scientific article published on February 2010

Biological agents alone or in combination as second-line therapy in advanced non-small-cell lung cancer: systematic review of randomized studies ⬇️

artículo científico publicado el 1 de octubre de 2012

Cisplatin or not in advanced gastric cancer: a systematic review and meta-analysis

artículo científico publicado en 2013

Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?

artículo científico publicado en 2009

Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-Analysis

artículo científico publicado en 2016

Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials ⬇️

artículo científico publicado el 6 de noviembre de 2011

Efficacy of fourth-line chemotherapy in advanced non-small-cell lung cancer: a systematic review and pooled analysis of published studies

artículo científico publicado en 2015

FOLFIRI-bevacizumab as first-line chemotherapy in 3500 patients with advanced colorectal cancer: a pooled analysis of 29 published trials

artículo científico publicado en 2013

Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue

artículo científico publicado en 2009

KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials

artículo científico publicado en 2013

Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis ⬇️

artículo científico publicado el 12 de junio de 2012

Neoadjuvant chemotherapy and concomitant trastuzumab in breast cancer: a pooled analysis of two randomized trials

scientific article published on February 2011

Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials

artículo científico publicado en 2017

Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: A Systematic Review and Meta-analysis.

artículo científico publicado en 2016

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis

artículo científico publicado en 2015

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

artículo científico publicado en 2005

Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: A literature-based meta-analysis of 24 trials ⬇️

artículo científico publicado el 12 de julio de 2012

Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies ⬇️

artículo científico publicado el 16 de agosto de 2011

Supportive care in patients with advanced non-small-cell lung cancer.

artículo científico publicado en 2003

Targeted therapies for the treatment of breast cancer in the post-trastuzumab era.

artículo científico publicado en 2008

The risk for anemia with targeted therapies for solid tumors

artículo científico publicado en 2012

Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes

artículo científico publicado en 2020

What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapies

artículo científico publicado en 2010

Lista de obras de

5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials ⬇️

A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer ⬇️

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials ⬇️

Benefit of adjuvant chemotherapy in elderly ER-negative breast cancer patients: benefits and pitfalls

Biological agents alone or in combination as second-line therapy in advanced non-small-cell lung cancer: systematic review of randomized studies ⬇️

Cisplatin or not in advanced gastric cancer: a systematic review and meta-analysis

Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?

Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-Analysis

Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials ⬇️

Efficacy of fourth-line chemotherapy in advanced non-small-cell lung cancer: a systematic review and pooled analysis of published studies

FOLFIRI-bevacizumab as first-line chemotherapy in 3500 patients with advanced colorectal cancer: a pooled analysis of 29 published trials

Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue

KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials

Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis ⬇️

Neoadjuvant chemotherapy and concomitant trastuzumab in breast cancer: a pooled analysis of two randomized trials

Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials

Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: A Systematic Review and Meta-analysis.

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: A literature-based meta-analysis of 24 trials ⬇️

Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies ⬇️

Supportive care in patients with advanced non-small-cell lung cancer.

Targeted therapies for the treatment of breast cancer in the post-trastuzumab era.

The risk for anemia with targeted therapies for solid tumors

Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes

What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapies